Answers are grounded in this paper and cite their sources.
Background Wheezing is a very common symptom in preschool children. Compared with that of older children with wheezing or asthma, the morbidity and health care utilization of preschool are disproportionately high, imposing a heavy economic burden on the health care system and society. Furthermore, severe and frequent wheezing in early life is associated with a trajectory of poor lung function, which is associated with respiratory and non-respiratory health outcomes in later adulthood, including high-risk chronic obstructive pulmonary disease and high-risk cardiovascular and cerebrovascular events in middle age. However, recurrent preschool wheezing, which is defined as two or more wheezing episodes in children younger than 6 years, excluding bronchiolitis, is highly heterogeneous in etiology and prognosis and poses significant diagnostic and therapeutic challenges for pediatricians. Methods Thirty Chinese experts majoring in pediatric pulmonology and epidemiology were invited to write this practical consensus on the diagnosis and treatment of recurrent wheezing in preschool children on the basis of evidence collection and experience. Elucidation and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wanfang databases. We used variations in terms for “wheezing”, “asthma”, “wheezing bronchitis”, “preschool”, “children”, and “pediatric”. Results The etiology, evaluation, management of acute wheezing exacerbation, and strategy of long-term anti-inflammatory therapy in recurrent preschool wheezing are highlighted. The most common causes of preschool wheezing are virus-induced wheezing and asthma (typical wheezing), some of which require long-term anti-inflammatory therapy. Some other children had identifiable underlying diseases (atypical wheezing). On the basis of the confirmation of wheezing, the underlying diseases and phenotypes of typical wheezing should be carefully investigated. For acute wheezing, inhaled short-acting β₂-agonists are the first-line agents, and systemic corticosteroids should be reserved only for severe cases. Routine use of azithromycin is not recommended in acute wheezing. The decision to initiate long-term anti-inflammatory therapy for recurrent preschool wheezing should be based on a comprehensive evaluation of clinical risk indicators and treatable traits such as type 2 inflammation. Immunomodulators such as bacterial lysates may be considered for use in trials in preschool children with recurrent virus-induced wheezing. Conclusions This symptom-based, phenotype-oriented consensus provides practical guidance for the individualized management of heterogeneous recurrent wheezing in preschool children. Further studies are needed to identify clinical risk factors and biomarkers for persistent wheezing and asthma. More appropriate long-term treatment regimens should also be explored.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: